Metabolite Ratios as Quality Indicators for Pre-Analytical Variation in Serum and EDTA Plasma.
Sven HeilingNadine KnuttiFranziska ScherrJörg GeigerJuliane WeikertMichael RoseRoland JahnsUta CeglarekAndré ScheragMichael KiehntopfPublished in: Metabolites (2021)
In clinical diagnostics and research, blood samples are one of the most frequently used materials. Nevertheless, exploring the chemical composition of human plasma and serum is challenging due to the highly dynamic influence of pre-analytical variation. A prominent example is the variability in pre-centrifugation delay (time-to-centrifugation; TTC). Quality indicators (QI) reflecting sample TTC are of utmost importance in assessing sample history and resulting sample quality, which is essential for accurate diagnostics and conclusive, reproducible research. In the present study, we subjected human blood to varying TTCs at room temperature prior to processing for plasma or serum preparation. Potential sample QIs were identified by Ultra high pressure liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) based metabolite profiling in samples from healthy volunteers (n = 10). Selected QIs were validated by a targeted MS/MS approach in two independent sets of samples from patients (n = 40 and n = 70). In serum, the hypoxanthine/guanosine (HG) and hypoxanthine/inosine (HI) ratios demonstrated high diagnostic performance (Sensitivity/Specificity > 80%) for the discrimination of samples with a TTC > 1 h. We identified several eicosanoids, such as 12-HETE, 15-(S)-HETE, 8-(S)-HETE, 12-oxo-HETE, (±)13-HODE and 12-(S)-HEPE as QIs for a pre-centrifugation delay > 2 h. 12-HETE, 12-oxo-HETE, 8-(S)-HETE, and 12-(S)-HEPE, and the HI- and HG-ratios could be validated in patient samples.
Keyphrases
- ms ms
- liquid chromatography tandem mass spectrometry
- room temperature
- simultaneous determination
- end stage renal disease
- quality improvement
- endothelial cells
- high resolution
- solid phase extraction
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- liquid chromatography
- mass spectrometry
- drug delivery
- high performance liquid chromatography
- cancer therapy
- human health
- patient reported